본문 바로가기
KERD
논문KCI 등재

2024 KSoLA consensus on secondary dyslipidemia

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.

Abstract

Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.

참고문헌 (68)

  1. Choi H, "Lipid-lowering efficacy of combination therapy with moderate-intensity statin and ezetimibe versus high-intensity statin monotherapy : a randomized, open-label, non-inferiority trial from Korea", J Lipid Atheroscler, 12, pp.277~289 (2023)
  2. Kang Y, "Moderate-intensity rosuvastatin", ezetimibe combination versus quadruple-dose rosuvastatin monotherapy : a meta-analysis and systemic review, 2024, pp.65, 19~26
  3. Park KY, "Trends in prevalence of hypertriglyceridemia and related factors in Korean adults : a serial cross-sectional study", J Lipid Atheroscler, 12, pp.201~212 (2023)
  4. Tarim BA, "Do statins counteract the effect of antidiabetic drugs? Results of the SCEAD study", Yonsei Med J, 64, pp.175~180 (2023)
  5. Mach F, "2019 ESC", EAS guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk, 2020, pp.41, 111~188
  6. Grundy SM, "2018 AHA", ACC, AAPA, pp.ABC, ACPM[DOI]
  7. Jin ES, "Dyslipidemia fact sheet in South Korea, 2022", J Lipid Atheroscler, 12, pp.237~251 (2023)
  8. Hong S, "Higher non-high-density lipoprotein cholesterol was higher associated with cardiovascular disease comparing higher LDL-C in nine years follow up : cohort study", J Lipid Atheroscler, 12, pp.164~174 (2023)
  9. Simha V, "Management of hypertriglyceridemia", BMJ, 371, pp.m3109~ (2020)
  10. Chen HJ, "Energy intake at different times of the day : Its association with elevated total and LDL cholesterol levels", Nutr Metab Cardiovasc Dis, 29, pp.390~397 (2019)
  11. Magriplis E, "Trans fatty acid intake increases likelihood of dyslipidemia especially among individuals with higher saturated fat consumption", Rev Cardiovasc Med, 23, pp.130~ (2022)
  12. Hu FB, "Types of dietary fat and risk of coronary heart disease : a critical review", J Am Coll Nutr, 20, pp.5~19 (2001)
  13. Sun Y, "Palm oil consumption increases LDL cholesterol compared with vegetable oils low in saturated fat in a meta-analysis of clinical trials", J Nutr, 145, pp.1549~1558 (2015)
  14. Fernandez ML, "Mechanisms by which dietary fatty acids modulate plasma lipids", J Nutr, 135, pp.2075~2078 (2005)
  15. Hannon BA, "Nutrigenetic contributions to dyslipidemia : a focus on physiologically relevant pathways of lipid and lipoprotein metabolism", Nutrients, 10, pp.1404~ (2018)
  16. Mozaffarian D, "Trans fatty acids and cardiovascular disease", N Engl J Med, 354, pp.1601~1613 (2006)
  17. Oteng AB, "Mechanisms of action of trans fatty acids", Adv Nutr, 11, pp.697~708 (2020)
  18. Jung CH, "Impact of high-carbohydrate diet on metabolic parameters in patients with type 2 diabetes", Nutrients, 9, pp.322~ (2017)
  19. Chawla S, "The effect of low-fat and low-carbohydrate diets on weight loss and lipid levels : a systematic review and meta-analysis", Nutrients, 12, pp.3774~ (2020)
  20. Dong T, "The effects of low-carbohydrate diets on cardiovascular risk factors : a meta-analysis", PLoS One, 15, pp.e0225348~ (2020)
  21. Fechner E, "The effects of different degrees of carbohydrate restriction and carbohydrate replacement on cardiometabolic risk markers in humans-a systematic review and meta-analysis", Nutrients, 12, pp.991~ (2020)
  22. David Wang D, "Effect of fructose on postprandial triglycerides : a systematic review and meta-analysis of controlled feeding trials", Atherosclerosis, 232, pp.125~133 (2014)
  23. Kim SA, "Red meat and processed meat consumption and the risk of dyslipidemia in Korean adults : a prospective cohort study based on the Health Examinees(HEXA)study", Nutr Metab Cardiovasc Dis, 31, pp.1714~1727 (2021)
  24. Welsh JA, "Caloric sweetener consumption and dyslipidemia among US adults", JAMA, 303, pp.1490~1497 (2010)
  25. Haslam DE, "Beverage consumption and longitudinal changes in lipoprotein concentrations and incident dyslipidemia in US adults : the Framingham Heart study", J Am Heart Assoc, 9, pp.e014083~ (2020)
  26. Stanhope KL, "Sugar consumption, metabolic disease and obesity : the state of the controversy", Crit Rev Clin Lab Sci, 53, pp.52~67 (2016)
  27. "Use of non-sugar sweeteners:WHO guideline" (2023)[URL]
  28. Donat-Vargas C, "High consumption of ultra-processed food is associated with incident dyslipidemia : a prospective study of older adults", J Nutr, 151, pp.2390~2398 (2021)
  29. Rimm EB, "Moderate alcohol intake and lower risk of coronary heart disease : meta-analysis of effects on lipids and haemostatic factors", BMJ, 319, pp.1523~1528 (1999)
  30. Rader DJ, "Harrison’s principles of internal medicine" (2018), McGraw-Hill Education
  31. Kwan TW, "Epidemiology of diabetes and atherosclerotic cardiovascular disease among Asian American adults : implications, management, and future directions : a scientific statement from the American Heart Association", Circulation, 148, pp.74~94 (2023)
  32. Lee J, "Association between dietary patterns and dyslipidemia in Korean women", Front Nutr, 8, pp.756257~ (2022)
  33. Lichtenstein AH, "2021 dietary guidance to improve cardiovascular health : a scientific statement from the American Heart Association", Circulation, 144, pp.e472~e487 (2021)
  34. Pasanisi F, "Benefits of sustained moderate weight loss in obesity", Nutr Metab Cardiovasc Dis, 11, pp.401~406 (2001)
  35. Kirkpatrick CF, "Nutrition interventions for adults with dyslipidemia : a clinical perspective from the National Lipid Association", J Clin Lipidol, 17, pp.428~451 (2023)
  36. Sacks FM, "Comparison of weightloss diets with different compositions of fat, protein, and carbohydrates", N Engl J Med, 360, pp.859~873 (2009)
  37. Application of 2020 dietary reference intakes for Koreans, "Ministry of Health and Welfare", Ministry of Health and Welfare, ~ (2021)
  38. Hooper L, "Reduction in saturated fat intake for cardiovascular disease", Cochrane Database Syst Rev, (6), pp.CD011737~ (2015)
  39. Hannon BA, "Clinical outcomes of dietary replacement of saturated fatty acids with unsaturated fat sources in adults with overweight and obesity : a systematic review and meta-analysis of randomized control trials", Ann Nutr Metab, 71, pp.107~117 (2017)
  40. Hooper L, "Reduction in saturated fat intake for cardiovascular disease", Cochrane Database Syst Rev, 5, pp.CD011737~ (2020)
  41. Guasch-Ferré M, "Meta-analysis of randomized controlled trials of red meat consumption in comparison with various comparison diets on cardiovascular risk factors", Circulation, 139, pp.1828~1845 (2019)
  42. Reynolds A, "Carbohydrate quality and human health : a series of systematic reviews and meta-analyses", Lancet, 393, pp.434~445 (2019)
  43. Soliman GA, "Dietary fiber, atherosclerosis, and cardiovascular disease", Nutrients, 11, pp.1155~ (2019)
  44. "Healthy diet" (2020)[URL]
  45. Visseren FLJ, "2021 ESC Guidelines on cardiovascular disease prevention in clinical practice", Eur Heart J, 42, pp.3227~3337 (2021)
  46. Virani SS, "2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia : a report of the American College of Cardiology Solution Set Oversight Committee", J Am Coll Cardiol, 78, pp.960~993 (2021)
  47. Snetselaar LG, "Dietary guidelines for Americans, 2020-2025 : understanding the scientific process, guidelines, and key recommendations", Nutr Today, 56, pp.287~295 (2021)
  48. Liu H, "Update on dyslipidemia in hypothyroidism : the mechanism of dyslipidemia in hypothyroidism", Endocr Connect, 11, pp.e210002~ (2022)
  49. Wah-Suarez MI, "Hyperlipidaemia in primary biliary cholangitis : treatment, safety and efficacy", Frontline Gastroenterol, 10, pp.401~408 (2019)
  50. Agrawal S, "Dyslipidaemia in nephrotic syndrome : mechanisms and treatment", Nat Rev Nephrol, 14, pp.57~70 (2018)
  51. Kotwal A, "Treatment of thyroid dysfunction and serum lipids : a systematic review and meta-analysis", J Clin Endocrinol Metab, 105, pp.dgaa672~ (2020)
  52. Mantel-Teeuwisse AK, "Drug-Induced lipid changes : a review of the unintended effects of some commonly used drugs on serum lipid levels", Drug Saf, 24, pp.443~456 (2001)
  53. Donahoo WT, "Drugs causing dyslipoproteinemia", Endocrinol Metab Clin North Am, 27, pp.677~697 (1998)
  54. Boots JM, "Effect of immunosuppressive agents on long-term survival of renal transplant recipients : focus on the cardiovascular risk", Drugs, 64, pp.2047~2073 (2004)
  55. Winegar DA, "Effects of cyclosporin on cholesterol 27-hydroxylation and LDL receptor activity in HepG2 cells", J Lipid Res, 37, pp.179~191 (1996)
  56. Myerson M, "Lipid management in human immunodeficiency virus", Endocrinol Metab Clin North Am, 45, pp.141~169 (2016)
  57. Nduka C, "Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias : a systematic review and meta-analysis", Int J Cardiol, 199, pp.307~318 (2015)
  58. Lazarte J, "Lipid effects of sodium-glucose cotransporter 2 inhibitors", Curr Opin Lipidol, 32, pp.183~190 (2021)
  59. Vergès B, "Pathophysiology of diabetic dyslipidaemia : where are we?", Diabetologia, 58, pp.886~899 (2015)
  60. Eckel RH, "The complex metabolic mechanisms relating obesity to hypertriglyceridemia", Arterioscler Thromb Vasc Biol, 31, pp.1946~1948 (2011)
  61. Vaziri ND, "Disorders of lipid metabolism in nephrotic syndrome : mechanisms and consequences", Kidney Int, 90, pp.41~52 (2016)
  62. Moradi H, "Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease", Front Biosci(Landmark Ed), 23, pp.146~161 (2018)
  63. de Carvalho JF, "Anti-lipoprotein lipase antibodies : a new player in the complex atherosclerotic process in systemic lupus erythematosus?", Arthritis Rheum, 50, pp.3610~3615 (2004)
  64. Yamamoto H, "Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody", J Clin Endocrinol Metab, 99, pp.1525~1530 (2014)
  65. Miyashita K, "Chylomicronemia from GPIHBP1 autoantibodies", J Lipid Res, 61, pp.1365~1376 (2020)
  66. Green P, "Lipid metabolism in critical illness", Curr Opin Clin Nutr Metab Care, 19, pp.111~115 (2016)
  67. Gupta M, "Prevention and management of hypertriglyceridemia-induced acute pancreatitis during pregnancy : a systematic review", Am J Med, 135, pp.709~714 (2022)
  68. Yoneyama K, "Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia", Breast J, 25, pp.788~789 (2019)

관련 논문AI추천

2024 KSoLA Consensus on Secondary Dyslipidemia강민지, 김민주, 배재현, 원호연, 이상학, 임현정한국지질동맥경화학회 · 지질·동맥경화학회지2024 · 제13권 제3호이차성 이상지질혈증에 대한 한국지질동맥경화학회 2024년 합의안강민지, 김민주, 배재현, 원호연, 이상학, 임현정, 한국지질동맥경화학회 진료지침위원회대한내과학회 · 대한내과학회지2025 · 제100권 제1호2018 Guidelines for the Management of Dyslipidemia in Korea김병진, 김은미, 김재현, 김현창, 김혜진, 나진오, 노정현, 문민경, 박광열, 송윤주, 오미선, 이경희, 이상학, 이은영, 이은정, 임정현, 정인경, 최성훈, 한상엽, 홍순철한국지질동맥경화학회 · 지질·동맥경화학회지2019 · 제8권 제2호Erratum : 이차성 이상지질혈증에 대한 한국지질동맥경화학회 2024년 합의안강민지, 김민주, 배재현, 원호연, 이상학, 임현정, 한국지질동맥경화학회 진료지침위원회대한내과학회 · 대한내과학회지2025 · 제100권 제3호Dyslipidemia Fact Sheet in Korea, 2022강신애, 김현창, 배재현, 원종철, 이호규, 정인경, 진흥용, Eun-Sun Jin, Jee-Seon Shim, Jenny Moon, Shin Min-Jeong, Sung Eun Kim한국지질동맥경화학회 · 지질·동맥경화학회지2023 · 제12권 제3호이상지질혈증의 국내 및 국외 치료 가이드라인 비교이송, 김주영, 이경은, 최윤정한국임상약학회 · 한국임상약학회지2017 · 제27권 제4호

이 간행물의 다른 논문 (17건)